Showing results (721-730 of 866) with videos related to
Sort By:
Pageof 87
Med (New York, N.Y.)|June 10, 2023
Oncogenic virus integration: Moving toward clinical applicationsPing Wu, Ding Ma, Peng WuMed (New York, N.Y.)|May 28, 2026
Capturing multi-disease states on a spectrum with machine learning and routine clinical dataIain S Forrest, Ben O Petrazzini, Robert Chen, et al.Med (New York, N.Y.)|May 28, 2026
Loss of tumor suppressor NF2 mediates resistance to CAR T cell and anti-PD-1 therapy: Strategies to restore immunotherapy sensitivityMiguel A Lopez-Lago, Meriem Taleb, Mehek Ningoo, et al.Med (New York, N.Y.)|June 12, 2026
Five trials reshaping multiple myelomaAlexis Talbot, Arthur Bobin, Cyrille Touzeau, et al.Med (New York, N.Y.)|June 12, 2026
Diabetic retinal disease: Five trials to watchHannah Khan, Aamir A Aziz, Arshad M Khanani, et al.Med (New York, N.Y.)|June 12, 2026
Resectability redefined: Lessons from quadruple therapy in HCCNan Jiang, Bin-Yan ZhongMed (New York, N.Y.)|June 12, 2026
A window to breathe againAndrés París-Muñoz, Rosa M Alcobendas-Rueda, Cristina Verdú-Sánchez, et al.Med (New York, N.Y.)|June 4, 2026
Gene therapy and cost-effectiveness analysis: Current issues and future researchScott Johnson, Marric Buessing, Thomas O'Connell, et al.Med (New York, N.Y.)|June 9, 2026
Single-cell profiling unveils an exhaustion trajectory of ZNF683hi tissue-resident alveolar CD8+ T cells in checkpoint inhibitor pneumonitisXiaoxiang Zhou, Ziming Jiang, Yanhong Ren, et al.Med (New York, N.Y.)|April 15, 2026
Ferroptosis in MASLD: From molecular mechanisms to therapeutic opportunitiesXiao-Dong Zhou, Qiong-Yue Fan, Giovanni Targher, et al.Pageof 87